Matches in Wikidata for { <http://www.wikidata.org/entity/Q91586224> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91586224 description "artículu científicu espublizáu en setiembre de 2016" @default.
- Q91586224 description "scientific article published on 27 September 2016" @default.
- Q91586224 description "wetenschappelijk artikel" @default.
- Q91586224 description "наукова стаття, опублікована у вересні 2016" @default.
- Q91586224 name "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 name "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 type Item @default.
- Q91586224 label "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 label "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 prefLabel "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 prefLabel "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 P1433 Q91586224-942FA789-518B-4922-963C-202C150238DA @default.
- Q91586224 P1476 Q91586224-499638B9-8D3A-4465-A73A-B3EE1ED9AD01 @default.
- Q91586224 P2093 Q91586224-11413E9D-1A5C-477C-A1CE-7A2903F71647 @default.
- Q91586224 P2093 Q91586224-625CFBFB-36D7-4E0E-9012-0C3E2A463E32 @default.
- Q91586224 P2093 Q91586224-63E28C87-4773-44A5-A319-1E9A61AF9209 @default.
- Q91586224 P2093 Q91586224-9B064196-C4C6-4332-9E1D-015A908D45F3 @default.
- Q91586224 P2093 Q91586224-FF451307-7879-4226-A8E4-78D89BE53179 @default.
- Q91586224 P304 Q91586224-2F75623A-75A8-409C-B839-2ABBA6553CA2 @default.
- Q91586224 P31 Q91586224-0F809A3F-42F4-40E9-80AB-CD2B37AFF31A @default.
- Q91586224 P356 Q91586224-6F43CD7C-9795-484D-BA66-90C3C11734A9 @default.
- Q91586224 P433 Q91586224-7DA14DAA-FBF7-41CD-842D-EC00128FEC3C @default.
- Q91586224 P478 Q91586224-5528F033-04F3-4540-802A-342279573953 @default.
- Q91586224 P577 Q91586224-698C452F-256F-4731-BE0F-C5E4C6EF10FF @default.
- Q91586224 P698 Q91586224-F39D387B-52FE-4114-BEA7-902205596859 @default.
- Q91586224 P921 Q91586224-AD6E3CBC-4CAC-4554-8355-6BCE7ED9C830 @default.
- Q91586224 P921 Q91586224-C80A4202-8069-4907-A669-BEC9ED183074 @default.
- Q91586224 P356 2168479016662682 @default.
- Q91586224 P698 30235998 @default.
- Q91586224 P1433 Q5308855 @default.
- Q91586224 P1476 "The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States" @default.
- Q91586224 P2093 "Hideyuki Kondo" @default.
- Q91586224 P2093 "Hisashi Koike" @default.
- Q91586224 P2093 "Konomi Ito" @default.
- Q91586224 P2093 "Noriatsu Kono" @default.
- Q91586224 P2093 "Toshiyuki Hata" @default.
- Q91586224 P304 "51-54" @default.
- Q91586224 P31 Q13442814 @default.
- Q91586224 P356 "10.1177/2168479016662682" @default.
- Q91586224 P433 "1" @default.
- Q91586224 P478 "51" @default.
- Q91586224 P577 "2016-09-27T00:00:00Z" @default.
- Q91586224 P698 "30235998" @default.
- Q91586224 P921 Q17 @default.
- Q91586224 P921 Q30 @default.